đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to show that subcutaneous (SC) administration ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2017-10-27
Trial ID
NCT03277105
The purpose of this study is to evaluate the effects of the addition of dar...
Status
Completed
Location
Antwerpen
Start Date
2017-06-14
Trial ID
NCT03180736
Treatments Being Tested
This phase 2 trial will test whether the combination of DaraRd (daratumumab...
Status
Active Not Recruiting
Location
University of Michigan Rogel Cancer Center
Start Date
2020-10-05
Trial ID
NCT04140162
Treatments Being Tested
The purpose of this study is to test the safety and efficacy of the study d...
Status
Terminated
Location
John Theurer Cancer Center
Start Date
2022-05-02
Trial ID
NCT04700176
Treatments Being Tested
This is a prospective and single arm clinical study. The goal of this clini...
Status
Unknown
Location
The First Affiliated Hospital of Wenzhou Medical University
Start Date
2024-03-01
Trial ID
NCT06455748
Treatments Being Tested
This phase I trial studies the possible benefits and side effects of adding...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2021-09-27
Trial ID
NCT04956302
Treatments Being Tested
This is an open-label, multicenter, Phase 2 study in subjects with newly di...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-06-15
Trial ID
NCT06418477
Treatments Being Tested
This study will independently assess the efficacy and safety of 11 combinat...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2015-10
Trial ID
NCT02343042
The study will investigate the effects of adding carfilzomib to the combina...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2012-08-13
Trial ID
NCT01665794
Treatments Being Tested
This is a single center, open-label, phase 2 study in elderly (age â„ 70) su...
Status
Active Not Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2019-10-24
Trial ID
NCT04052880
Treatments Being Tested